Definition of the dependence of QTc interval prolongation on glycemic control in patients with type 2 diabetes mellitus
DOI:
https://doi.org/10.26641/2307-0404.2022.1.254326Keywords:
diabetes mellitus type 2, QTc interval, glycemic variabilityAbstract
The aim of the study: to assess the impact of glycemic variability on the duration of QTc interval in patients with diabetes mellitus type 2. 68 patients with type 2 diabetes mellitus (DM) and glycosylated hemoglobin (HbA1c) level ≤10% were examined. Of them – 37 (54.4%) men and 31 (45.6%) women. The average age – 46.0 (43.0; 54.0) years, the duration of DM type 2 – 7.0 (5.0; 9.0) years. Patients were divided into 2 groups according to HbA1c level: group 1 (n=31) with HbA1c <7% and group 2 (n=37) with HbA1c ≥7%. The control group consisted of 10 practically healthy people, compared by gender and age. The duration of the QTc interval was calculated automatically by Bazett's formula during 24-hour Holter electrocardiogram (ECG) recordings. Additionally, the percentage of cases of exceeding the QTc threshold over 450 ms (QTc>450) was also calculated. Simultaneously with 24-hour Holter monitoring, the continuous glucose monitoring was performed, using iPro2 system (Medtronic MiniMed, USA). The maximum value of glycemia (Gmax), the minimum value of glycemia (Gmin), as well as indicators of glycemia variability (GV) were analyzed: standard deviation of mean glycemia (SD) and glycemia range (GR). The duration of daily QTc and the value of QTc >450 in patients with type 2 DM were significantly greater compared with the control group (p<0.05) and did not depend on the HbA1c level. In type 2 DM patients without recorded hypoglycemic episodes, the characteristics of QTc did not differ from the results of the control group (p>0.05). At the time of the hypoglycemic episode, the QTc duration in patients with type 2 DM significantly increased compared with the average daily value of QTc in the same patients – 487 (466; 519.5) ms against 436.5 (431; 452) ms (p<0.001). A strong correlation between QTc duration and the presence of hypoglycemia was determined (rs=0.78; p=0.023). QTc duration also correlated with GR (rs=0.23; p=0.016) and SD (rs=0.21; p=0.021). Therefore, it was found that in patients with type 2 diabetes, the prolongation of QTc duration is associated with high glycemic fluctuations and hypoglycemia (p<0.05) regardless of the HbA1c level.
References
Antomonov MYu. [Mathematical processing and analysis of Biomedical data]. 2-nd ed. Kyiv: Medinform; 2018. p. 579. Russian.
American Diabetes Association. Standards of Medical Care in Diabetes- 2016: Summary of Revisions. Diabetes Care. 2021;44(Suppl 1). Available from: https://care.diabetesjournals.org/content/diacare/suppl/2020/12/09/44.Supplement_1.DC1/DC_44_S1_final_copyright_stamped.pdf
Jaiswal M, McKeon K, Comment N, Henderson J, Swanson S, Plunkett C, et al. Association between impaired cardiovascular autonomic function and hypogly¬cemia in patients with type 1 diabetes. Diabetes Care. 2014;37(9):2616‐21.
doi: https://doi.org/10.2337/dc14-0445
Jensen MH, Dethlefsen C, Hejlesen O, Vestergaard P. Association of severe hypoglycemia with mor¬tality for people with diabetes mellitus during a 20-year follow-up in Denmark: a cohort study. Acta Diabetol. 2020;57(5):549‐58.
doi: https://doi.org/10.1007/s00592-019-01447-x
El-Sherif N, Turitto G, Boutjdir M. Acquired long QT syndrome and torsade de pointes. Pacing Clin Electrophysiol. 2018;41(4):414-21. doi: https://doi.org/10.1111/pace.13296.
Hnatkova K, Vicente J, Johannesen L, Garnett C, Stockbridge N, Malik M. Errors of Fixed QT Heart Rate Corrections Used in the Assessment of Drug-Induced QTc Changes. Front Physiol. 2019;10:635. doi: https://doi.org/10.3389/fphys.2019.00635
Liang S, Yin H, Wei C, Xie L, He H, Liu X. Glucose variability for cardiovascular risk factors in type 2 dia¬betes: a meta-analysis. J Diabetes Metab Disord. 2017;16:45. doi: https://doi.org/10.1186/s40200-017-0323-5
Omran J, Bostick BP, Chan AK, Alpert MA. Obesity and Ventricular Repolarization: a Comprehensive Review. Prog Cardiovasc Dis. 2018;61(2):124-35. doi: https://doi.org/10.1016/j.pcad.2018.04.004
Tsioufis C, Andrikou E, Thomopoulos C, Papanas N, Tousoulis D. Oral Glucose-lowering Drugs and Cardiovascular Outcomes: From the Negative RECORD and ACCORD to Neutral TECOS and Promising EMPA-REG. Curr Vasc Pharmacol. 2017;15(5):457-68. doi: https://doi.org/10.2174/1570161114666161208150642
Rezuş C, Moga VD, Ouatu A, Floria M. QT interval variations and mortality risk: is there any relationship? Anatol J Cardiol. 2015;15(3):255-8. doi: https://doi.org/10.5152/akd.2015.5875
Kacheva S, Karges B, Göller K, Marx N, Mischke K, Karges W. QT prolongation caused by insulin-induced hypoglycaemia – An interventional study in 119 individuals. Diabetes Res Clin Pract. 2017;123:165‐72. doi: https://doi.org/10.1016/j.diabres.2016.11.021
Tanenberg RJ, Newton CA, Drake AJ. Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose moni¬toring system. Endocr Pract. 2010;16(2):244-8. doi: https://doi.org/10.4158/EP09260.CR.
Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med. 1991;8(1):49‐58. doi: https://doi.org/10.1111/j.1464-5491.1991.tb01516.x
Wei W, Zhao S, Fu SL, Yi L, Mao H, Tan Q, et al. The Association of Hypoglycemia Assessed by Conti¬nuous Glucose Monitoring With Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes. Front Endocrinol (Lausanne). 2019;10:536. doi: https://doi.org/10.3389/fendo.2019.00536
Sertbas Y, Ozdemir A, Sertbas M, Dayan A, Sancak S, Uyan C. The Effect of Glucose Variability on QTc Duration and Dispersion in Patients with Type 2 Diabetes Mellitus. Pak J Med Sci. 2017;33(1):22-26. doi: https://doi.org/10.12669/pjms.331.11440
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
